课题基金 / 基金详情

Understanding the Pathogenic Mechanisms of Rett Syndrome

Understanding the Pathogenic Mechanisms of Rett Syndrome
了解雷特综合征的发病机制
批准号:
10656152
负责人:
Zhaolan Zhou
金额:
$52.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-01 至 2024-06-30

项目摘要

项目成果

Zhaolan Zhou的其他基金

相似基金

相关文献

中文摘要
翻译
甲基CpG结合蛋白2(MECP2)基因突变导致Rett综合征(RTT) 每10,000名女孩中就有1人患有神经发育障碍。为了了解RTT的发病机制, 我们以前开发并描述了重述RTT相关错义的小鼠模型 突变,MeCP2 T158M和R106W,并检查了MeCP2依赖的基因表达程序 感兴趣的神经细胞类型。我们发现1)这两个突变都削弱了MeCP2与染色质的结合, 导致小鼠出现RTT样表型,但MeCP2突变蛋白表达的升高增加了 MeCP2与染色质结合并改善体内RTT样表型,提出了一个新的方向 发展RTT的治疗方法;2)MeCP2在前脑GABA能中发挥必要和充分的作用 介导神经元事件相关电位的中间神经元支持MeCP2的关键作用 规范信息处理;以及3)通过开发依赖于CRE的生物素标记系统,我们 发现MeCP2在依赖突变的、细胞类型特异的、以及在 细胞和非细胞的自主方式,特别是在花叶雌体中。这些发现已经设定了 揭示MeCP2调控细胞类型特异性基因的分子机制的前提 表达,研究杂合子女性RTT的分子病因学,并检验 依赖于MeCP2的分子通路是RTT发病机制的基础。结合在一起 遗传、基因组、分子和细胞方法,我们希望不仅揭示对 RTT的发病机制,也是为了加快以机制为基础的治疗学的发展 提高RTT的治疗水平。此外,我们建议的研究将为研究界提供 拥有创新的工具和资源来研究各种疾病的表观遗传机制 生物过程和疾病。
英文摘要
Mutations in methyl-CpG binding protein 2 (MECP2) gene cause Rett Syndrome (RTT), a neurodevelopmental disorder that afflicts about 1 in 10,000 girls. To understand the pathogenesis of RTT, we previously developed and characterized mouse models recapitulating RTT-associated missense mutations, MeCP2 T158M and R106W, and examined MeCP2-dependent gene expression programs in neuronal cell types of interest. We found that 1) both mutations impair MeCP2 binding to chromatin, resulting in RTT-like phenotypes in mice, but, elevation of MeCP2 mutant protein expression increase the binding of MeCP2 to chromatin and ameliorate RTT-like phenotypes in vivo, raising a new direction to develop therapeutics for RTT; 2) MeCP2 plays a necessary and sufficient role in forebrain GABAergic interneurons mediating neuronal event-related potentials (ERPs), supporting a key role for MeCP2 to regulate information processing; and 3) By developing a Cre-dependent biotin tagging system, we uncovered that MeCP2 modulates gene transcription in a mutation-dependent, cell type-specific, and in both cell and non-cell autonomous manner, particularly in mosaic females. These findings have set the premise to uncover the molecular mechanisms by which MeCP2 modulates cell type-specific gene expression, investigate the molecular etiology of RTT in heterozygous females, and test the causality of MeCP2-dependent molecular pathways that underlie the pathogenesis of RTT. With the combined genetic, genomic, molecular and cellular approaches, we hope to not only reveal novel insight into the pathogenic mechanisms of RTT, but also to expedite the development of mechanism-based therapeutics to improve treatment for RTT. Moreover, our proposed study will provide the research community at large with innovative tools and resources to investigate the epigenetic mechanisms underlying a variety of biological processes and diseases.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.fob.2015.08.010
发表时间: 2015
期刊: FEBS open bio
影响因子: 2.6
作者: [Manners MT, Tian Y, Zhou Z, Ajit SK]
通讯作者: Ajit SK
Preclinical Models Core
  • 批准号:
    10450698
  • 项目类别:
  • 资助金额:
    $17.47万
  • 财政年份:
    2021
  • 负责人:
    Zhaolan Zhou
  • 依托单位:
Preclinical Models Core
  • 批准号:
    10678904
  • 项目类别:
  • 资助金额:
    $17.47万
  • 财政年份:
    2021
  • 负责人:
    Zhaolan Zhou
  • 依托单位:
Preclinical Models Core
  • 批准号:
    10240004
  • 项目类别:
  • 资助金额:
    $18.91万
  • 财政年份:
    2021
  • 负责人:
    Zhaolan Zhou
  • 依托单位:
Neuropathogenic Studies of Congenital Disorders of Glycosylation
  • 批准号:
    9979478
  • 项目类别:
  • 资助金额:
    $44.6万
  • 财政年份:
    2020
  • 负责人:
    Zhaolan Zhou
  • 依托单位:
海外基金